Benchmark Holdings PLC (LON:BMK)

Benchmark Holdings PLC (LON:BMK)


Share Price
52.50 p
Change
0 (0.00 %)
Market Cap
£293.05 m
Proactive Investors - Run By Investors For Investors

Benchmark Holdings PLC

DRIVING SUSTAINABILITY IN FOOD PRODUCTION

Benchmark is a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, and by reducing mortality. Our main products are salmon eggs with superior genetic...

EPIC: BMK
Market: AIM:BMK
52-week High/Low: 64.00p / 38.00p
Sector: Pharma & Biotech
Market Cap: £293.05 m
Website: www.benchmarkplc.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Benchmark Holdings PLC


Benchmark Holdings PLC Snapshot

WHAT WE STAND FOR

Our aim is to set a new benchmark for sustainable living — starting with food production. We do this by;

-       Harnessing the best expertise


-       Deploying cutting-edge technologies

-       Embedding ourselves alongside our customers, providing local support and expert advice in all key markets

 

Taking aquaculture diagnostics into the digital age – we have transferred human cancer cell screening techniques to aquaculture enabling earlier disease identification. Find out more.

A leading provider of technical genetic services across all of the major aquatic farmed species. 

Our technology is at the forefront of our industry. Our people are right there next to the farmers. Find our more.

Improving and promoting the health and welfare of animals is core to our work. Find out more.

United Kingdom, USA), Thailand, Norway, Chile and Brazil. 

Click here for locations.


 

PETER GEORGE
Non-Executive Chairman

MALCOLM PYE
Chief Executive Officer

MARK PLAMPIN
Chief Financial Officer

ALEX RAEBER
Chief Scientific Officer

HUGO WAHNISH
Non-Executive Director

KEVIN QUINN
Non-Executive Director

SUSAN SEARLE
Non-Executive Director

YNGVE MYHRE
Non-Executive Director

JENNIFER HADDOUK
Company Secretary & Group Legal Counsel

KRISTIAN EIKRE
Non-Executive Director

AIM Securities in issue, and Significant Shareholders (as at 8 July 2019)

The total number of AIM securities in issue is 558,228,309 ordinary shares of 0.1 penny each, none of which are held in treasury.

64.77% of shares are not in public hands.

There are no restrictions on the transfer of Benchmark plc’s AIM securities.

Details of other exchanges or trading platforms

The company is not listed on any other exchanges or trading platforms

Significant Shareholders as notified to the Company

SIGNIFICANT SHAREHOLDERS % OF ISSUED SHARE CAPITAL
FERD AS 26.01
Invesco Asset Management Ltd 15.11
Kverva Finans AS 11.47
Lansdowne Partners 9.24
The Royal Bank of Scotland Group plc 5.80
Harwood Capital 4.14

 

Registered Address
Benchmark Holdings PLC
Benchmark House,
8 Smithy Wood Drive,
Sheffield,
S35 1QN, UK

+44 (0)114 240 9939

[email protected]

London Office
20 Midtown
20 Procter Street
London
WC1V 6NX

+44 (0) 20 3915 1236

Edinburgh Office
Bush House
Edinburgh Technopole
Edinburgh EH26 0BB

+44 (0)131 445 8676

Media and Investor Enquiries
MHP Communications
6 Agar Street
London
WC2N 4HN

+44 (0)20 3128 8100

[email protected]

BENCHMARK HOLDINGS PLC

Benchmark House,
8 Smithy Wood Drive,
Sheffield,
S35 1QN, UK

+44 (0)114 240 9939

[email protected]

FINANCIAL PUBLIC RELATIONS

MHP Communications

6 Agar Street
London
WC2N 4HN

+44 (0)20 3128 8100

[email protected]

Columns Including BMK

VIEW ALL

Market Reports Including BMK

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use